ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 783

$891K Total Retail Price of All Prescriptions

Rank: 70 out of 783

616 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,814 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 876 747 1 4
LEVOTHYROXINE SODIUM 670 532 2 1
SIMVASTATIN 599 519 3 3
HYDROCODONE-ACETAMINOPHEN 562 383 S3 4 2
AMLODIPINE BESYLATE 548 485 5 5
OMEPRAZOLE 535 407 6 6
HYDROCHLOROTHIAZIDE 510 477 7 12
WARFARIN SODIUM 407 341 8 10
METFORMIN HCL 387 309 9 8
FUROSEMIDE 379 308 10 7
GLIMEPIRIDE 373 308 11 34
METOPROLOL TARTRATE 366 317 12 9
PRAVASTATIN SODIUM 328 249 13 14
LOVASTATIN 322 274 14 58
POTASSIUM CHLORIDE 311 219 15 16
SERTRALINE HCL 290 246 16 22
GABAPENTIN 290 248 16 15
METOPROLOL SUCCINATE 265 235 18 13
RANITIDINE HCL 234 167 19 44
TRIAMTERENE-HCTZ 207 171 20 42
FLUOXETINE HCL 207 138 20 45
POLYETHYLENE GLYCOL 3350 195 147 22 43
TAMSULOSIN HCL 189 169 23 26
ZOLPIDEM TARTRATE 189 138 23 23
CITALOPRAM HBR 186 181 25 19
ATENOLOL 175 171 26 17
DOXAZOSIN MESYLATE 162 143 27 87
TRAMADOL HCL 154 125 28 20
TRAZODONE HCL 145 118 29 39
BUPROPION HCL SR 145 117 29 166
ATORVASTATIN CALCIUM 144 120 31 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 142 127 32 33
LOSARTAN POTASSIUM 139 122 33 18
PREDNISONE 137 117 34 36
ADVAIR DISKUS 132 114 35 50
NIFEDIPINE ER 131 120 36 135
ALLOPURINOL 127 110 37 31
GEMFIBROZIL 127 71 37 105
MIRTAZAPINE 117 83 39 52
DIGOXIN 114 98 40 61
CARVEDILOL 112 88 41 21
CLOPIDOGREL 103 103 42 29
CYMBALTA 99 48 43 35
FLUTICASONE PROPIONATE 95 88 44 46
ROPINIROLE HCL 94 83 45 74
NEXIUM 88 67 46 28
KLOR-CON M20 88 76 46 48
DONEPEZIL HCL 87 86 48 24
QUETIAPINE FUMARATE 86 73 49 79
OXYBUTYNIN CHLORIDE ER 84 63 50 117
LEVEMIR 83 47 51 162
IPRATROPIUM-ALBUTEROL 83 73 51 110
ALENDRONATE SODIUM 83 67 51 25
FAMOTIDINE 82 67 54 55
OLANZAPINE 82 49 54 108
AZITHROMYCIN 80 74 56 41
CIPROFLOXACIN HCL 78 61 57 62
AMITRIPTYLINE HCL 78 54 R 57 77
OXYBUTYNIN CHLORIDE 77 58 59 96
PROAIR HFA 76 68 60 56
PAROXETINE HCL 74 49 61 69
HUMALOG 73 44 62 101
HUMULIN N 73 72 62 245
INSULIN SYRINGE 72 70 64 82
PLAVIX 70 67 65 51
PANTOPRAZOLE SODIUM 69 67 66 30
DIVALPROEX SODIUM 69 30 66 72
SPIRIVA 68 67 68 59
CRESTOR 67 67 69 27
NYSTATIN 67 48 69 106
NOVOLOG 66 64 71 81
CEPHALEXIN 66 50 71 70
ISOSORBIDE MONONITRATE ER 64 64 73 40
ESCITALOPRAM OXALATE 63 45 74 54
EVISTA 62 57 75 92
DIOVAN 61 60 76 49
SYNTHROID 58 58 77 47
LOSARTAN-HYDROCHLOROTHIAZIDE 57 53 78 53
LEVETIRACETAM 54 19 79 89
PROMETHAZINE HCL 52 29 R 80 97
TRIAMTERENE-HYDROCHLOROTHIAZID 51 45 81 173
PHENYTOIN SODIUM EXTENDED 50 17 82 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.